3 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 3 of 3 clinical reviews.
Evidence-based review of ezetimibe (Zetia) efficacy differences in Black and African ancestry populations, including IMPROVE-IT subgroup data, NPC1L1 pharmacogenomics, and clinical dosing guidance.
Evidence-based guide to ezetimibe (Zetia) dosing in East Asian populations, covering pharmacogenomic differences, clinical trial subgroup data, and practical prescribing considerations.
A clinician-reviewed guide to ezetimibe (Zetia) safety, pharmacogenomics, and dosing considerations specific to Hispanic and Latino patients, including IMPROVE-IT subgroup data, CYP2C8 variants, and diabetes risk.